|
National
Biotech Strategy envisages measures to raise investments
The National Biotech Strategy proposes a series of initiatives
to peg up investment in the sector and to strengthen human
resources with an objective of achieving a turnover of $5
billion and creation of one billion jobs by 2010.
ICMR
throws spanner into IISc’s scheme on rifampicin, INH
against malaria
The Bangalore based Indian Institute of Science (IISc) effort
to use rifampicin and INH (isoniazid), the drugs used in tuberculosis,
for fighting malaria caused by chloroquin-resistant Plasmodium
falciparum in direct human clinical trials received a set
back as the Indian Council of Medical Research (ICMR) has
asked them to do trials in primates first.
TDB
joins hands with APIDC-VCL for co-investment scheme
The Technology Development Board, under the Department of
Science & Technology, has allied with APIDC Venture Capital
Ltd to provide financial support to technology projects through
a Co-Investment Scheme.
|
